1. Signaling Pathways
  2. Anti-infection
  3. Bacterial

Bacterial

Anything that destroys bacteria or suppresses their growth or their ability to reproduce. Heat, chemicals such as chlorine, and antibiotic drugs all have antibacterial properties. Many antibacterial products for cleaning and handwashing are sold today. Such products do not reduce the risk for symptoms of viral infectious diseases in otherwise healthy persons. This does not preclude the potential contribution of antibacterial products to reducing symptoms of bacterial diseases in the home.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-170688
    Antibacterial agent 119
    Inhibitor
    Antibacterial agent 119 (Compound 21 g) is an antibacterial candidate against Methicillin (HY-121544)-resistant Staphylococcus aureus (MICs less than 1 μg/mL against tested strains). Antibacterial agent 119 induces ROS production. Antibacterial agent 119 also acts on the bacterial cell membrane to cause membrane breakage. Antibacterial agent 119 exhibits potent antibacterial activity with low cytotoxicity, rapid bactericidal ability, and good in vivo antibacterial activity.
    Antibacterial agent 119
  • HY-N14884
    Mureidomycin E
    Inhibitor
    Mureidomycin E is an antibiotic with anti-Pseudomonas aeruginosa activity.
    Mureidomycin E
  • HY-120203
    DA 1131
    Inhibitor
    DA 1131 is an anionic Carbapenem antibiotic. DA 1131 has broad spectrum antibacterial activity for both gram-positive and gram-negative organisms. DA 1131 is resistant to degradation by various types of β-lactamases.
    DA 1131
  • HY-B1374S2
    Florfenicol-13C6
    Inhibitor
    Florfenicol-13C6 (SCH-25298-13C6) is 13C labeled Florfenicol. Florfenicol ((-)-Florfenicol) is an orally active broad-spectrum antibacterial antibiotic with anti-inflammatory, pro apoptotic, and immunomodulatory functions.
    Florfenicol-<sup>13</sup>C<sub>6</sub>
  • HY-17580R
    Fidaxomicin (Standard)
    Inhibitor
    Fidaxomicin (Standard) is the analytical standard of Fidaxomicin. This product is intended for research and analytical applications. Fidaxomicin (OPT-80), a macrocyclic antibiotic, is an orally active and potent RNA polymerase inhibitor. Fidaxomicin has a narrow spectrum of antibacterial activity and a good anti-Clostridium difficile activity (MIC90=0.12 μg/mL). Fidaxomicin can be used for Clostridium difficile infection (CDI) research.
    Fidaxomicin (Standard)
  • HY-174389
    Antibacterial agent 283
    Inhibitor
    Antibacterial agent 283 (Compound 13) is an antimicrobial agent. Antibacterial agent 283 is active against both Gram-positive and Gram-negative bacteria, with potency comparable to the antibiotic Ampicillin (HY-B0522).
    Antibacterial agent 283
  • HY-N14143
    Citreamicin η
    Inhibitor
    Citreamicin η has anti-Gram-positive aerobic and anaerobic bacterial activities.
    Citreamicin η
  • HY-A0111A
    Cefetamet sodium
    Cefetamet sodium is a cephalosporin antibiotic. Cefetamet sodium has the potential for the research of both upper and lower community-acquired respiratory tract infections.
    Cefetamet sodium
  • HY-16752R
    Relebactam (Standard)
    Inhibitor
    Relebactam (Standard) is the analytical standard of Relebactam. This product is intended for research and analytical applications. Relebactam is a diazabicyclooctane inhibitor with activity against a wide spectrum of β-lactamases, including class A (extended-spectrum β-lactamases and KPC) and class C (AmpC) enzymes. Relebactam shows antibacterial activity.
    Relebactam (Standard)
  • HY-B0220F
    Erythromycin (glutamate)
    Inhibitor
    Erythromycin glutamate is a macrolide antibiotic produced by actinomycete Streptomyces erythreus with a broad spectrum of antimicrobial activity. Erythromycin glutamate binds to bacterial 50S ribosomal subunits and inhibits RNA-dependent protein synthesis by blockage of transpeptidation and/or translocation reactions, without affecting synthesis of nucleic acid[1][2]. Erythromycin glutamate also exhibits antitumor and neuroprotective effect in different fields of research[3][4].
    Erythromycin (glutamate)
  • HY-B1784R
    Sulfisomidin (Standard)
    Inhibitor
    Sulfisomidin (Standard) is the analytical standard of Sulfisomidin. This product is intended for research and analytical applications. Sulfisomidin (Sulfaisodimidine) is an orally active short-acting sulfonamide antibacterial. Sulfisomidin can be used for the research of lower urinary tract infections.
    Sulfisomidin (Standard)
  • HY-N14501
    Mycinamicin Ⅲ
    Inhibitor
    Monamycin III is an ester peptide antibiotic. Monamycin III has activity against Gram-positive bacteria.
    Mycinamicin Ⅲ
  • HY-17390R
    Loxapine (Standard)
    Inhibitor
    Loxapine (Standard) is the analytical standard of Loxapine. This product is intended for research and analytical applications. Loxapine is an orally active dopamine inhibitor, 5-HT receptor antagonist and also a dibenzoxazepine anti-psychotic agent.
    Loxapine (Standard)
  • HY-14879S2
    Avibactam sodium salt-13C5
    Inhibitor
    Avibactam sodium salt-13C5 (NXL-104-13C5) is 13C labeled Avibactam (sodium). Avibactam sodium (NXL-104) is a covalent and reversible non-β-lactam β-lactamase inhibitor which inhibits β-lactamase TEM-1 and CTX-M-15 with IC50s of 8 nM and 5 nM, respectively.
    Avibactam sodium salt-<sup>13</sup>C<sub>5</sub>
  • HY-B1246R
    Thonzonium bromide (Standard)
    Inhibitor
    Thonzonium (bromide) (Standard) is the analytical standard of Thonzonium (bromide). This product is intended for research and analytical applications. Thonzonium bromide is an antibacterial agent that is structurally similar to Farnesol (HY-Y0248A). Thonzonium bromide is also a monocationic surface-active agent, which inhibits RANKL-induced osteoclast formation and bone resorption in vitro and prevents LPS-induced bone loss in vivo. Thonzonium bromide inhibits proton transport in a dose-dependent manner (EC50=69 μM).
    Thonzonium bromide (Standard)
  • HY-N14139
    Dioxamycin
    Inhibitor
    Dioxamycin has anti-Gram-positive bacterial activity. Dioxamycin can inhibit Staphylococcus aureus 209P with a MIC of 3.12 μg/mL. Dioxamycin inhibits the growth of L1210, P388, IMC, LX-1 and SC-6 cells with IC50s (μg/mL) of 2.7, 1.4, 6.0, 2.0 and 2.5, respectively.
    Dioxamycin
  • HY-N14657
    Paulomycin A2
    Inhibitor
    Paulomycin A2 has anti-Gram-positive bacteria effect, and it has inhibitory effect on Staphylococcus aureus resistant to penicillin, Streptomycin, Neomycin and Macrolide antibiotics.
    Paulomycin A2
  • HY-N8221
    Homoembelin
    Inhibitor
    Homoembelin is an antimicrobial compound and has the potential for MDR bacterial infection research.
    Homoembelin
  • HY-157315
    Fabl inhibitor 21272541
    Inhibitor
    21272541 is a potent inhibitor of FabI protein. 21272541 significantly inhibits the infections caused by Gram-negative organisms.
    Fabl inhibitor 21272541
  • HY-N14320
    Lactaroviolin
    Inhibitor
    Lactaroviolin is an aromatic derivative antibiotic. Lactaroviolin can inhibit the growth of Mycobacterium tuberculosis, but the effect is not strong.
    Lactaroviolin
Cat. No. Product Name / Synonyms Application Reactivity